UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

08:30: Targeted Tumor-Selective Thromboses by Liposomal Paclitaxel

Otolaryngology-head and neck surgery, 2007-08, Vol.137 (2), p.P57-P57

2007

Volltextzugriff (PDF)

1556: TRACHEOSTOMY AND GASTROSTOMY IN GERIATRIC TRAUMA ASSOCIATED WITH HIGH POST-DISCHARGE MORTALITY

Critical care medicine, 2018-01, Vol.46 (1 Suppl 1), p.762-762

2018

Volltextzugriff (PDF)

2006 expressed-sequence tags derived from human chromosome 7-enriched cDNA libraries

Genome research, 1997-03, Vol.7 (3), p.281-292

1997

Volltextzugriff (PDF)

21 SELF IMAGE OF ADOLESCENTS WITH SHORT STATURE AS MEASURED BY HUMAN FIGURE DRAWINGS

Pediatric research, 1978-04, Vol.12, p.367-367

1978

Volltextzugriff (PDF)

The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR

Nucleic acids research, 2002-03, Vol.30 (5), p.1205-1212

2002

Volltextzugriff (PDF)

A 32-year experience in 100 patients with giant paraesophageal hernia : The case for abdominal approach and selective antireflux repair. Discussion

Surgery, 2000, Vol.128 (4), p.623-630

2000

Volltextzugriff (PDF)

6.57 Identifying Associations Between Phonology and Mental Health

Journal of the American Academy of Child and Adolescent Psychiatry, 2017-10, Vol.56 (10), p.S296-S296

2017

Volltextzugriff (PDF)

[8] Structural studies of DNA three-way junctions

Methods in Enzymology, 1995, Vol.261, p.183-207

1995

Volltextzugriff (PDF)

911 Spleen Preserving Laparoscopic Distal Pancreatectomy for a Solid Pseudopapillary Tumor in a Male Patient. (This Video Demonstrates Technical Details of a Rare Tumor of the Pancreas in a Male Patient. Only Few Cases Have Been Reported in Males)

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-1065-S-1065

2013

Volltextzugriff (PDF)

Abdominal Complications after Severe Burns. Discussion

Journal of the American College of Surgeons, 2009, Vol.208 (5), p.940-949

2009

Volltextzugriff (PDF)

About the Author

Categorical and Nonparametric Data Analysis, 2014

Nussbaum, E. Michael

2014

Volltextzugriff (PDF)

About the Authors

Categorical and Nonparametric Data Analysis, 2024

Nussbaum, E. Michael

2024

Volltextzugriff (PDF)

About the Contributors

Signs: Journal of Women in Culture and Society, 2004-01, Vol.29 (2), p.681-689

2004

Volltextzugriff (PDF)

Abstract 1129: How to develop ACC1 inhibitors targeting lipid metabolism and oncogenic signaling pathways effectively and safely

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1129-1129

2015

Volltextzugriff (PDF)

Abstract 1321: Castration-resistant prostate cancer: BAY 1024767 blocks function of mutated androgen receptor

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1321-1321

2013

Volltextzugriff (PDF)

Abstract 1887: Preclinical evaluation of a novel interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor in combination with PI3K inhibitor copanlisib or BTK inhibitors in ABC-DLBCL

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1887-1887

2018

Volltextzugriff (PDF)

Abstract 1921: Universal genetic testing for hereditary cancer syndromes in an under-represented minority population

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1921-1921

2023

Volltextzugriff (PDF)

Abstract 2718: Synthesis and characterization of novel benzylpyrazole-based BUB1 kinase inhibitors with anti-tumor activity

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2718-2718

2016

Volltextzugriff (PDF)

Abstract 2828: Rapid identification of potent and highly selective, oral PTEFb Inhibitor BAY 1143572 with first in class potential

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2828-2828

2015

Volltextzugriff (PDF)

Abstract 287: BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.287-287

2017

Volltextzugriff (PDF)

Abstract 3022: BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFb/CDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia (AML)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3022-3022

2016

Volltextzugriff (PDF)

Abstract 3022: BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFbCDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia (AML)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3022-3022

2016

Volltextzugriff (PDF)

Abstract 3090: Novel Mps1 kinase inhibitors with potent anti-tumor activity

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3090-3090

2015

Volltextzugriff (PDF)

Abstract 4538: BAY 1112054, a highly selective, potent and orally available inhibitor of PTEFb/CDK9, shows convincing anti-tumor activity

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4538-4538

2014

Volltextzugriff (PDF)

Abstract 4851: Second generation 2,3-dihydroimidazo[1,2-c]quinazoline PI3K inhibitors: development of BAY 1082439, a novel balanced PI3Ká / PI3Kâ inhibitor

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4851-4851

2016

Volltextzugriff (PDF)

1 – 25 von 765

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(636)
Mit Volltextzugriff
(663)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(750)
Deutsch
(13)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

08:30: Targeted Tumor-Selective Thromboses by Liposomal Paclitaxel

1556: TRACHEOSTOMY AND GASTROSTOMY IN GERIATRIC TRAUMA ASSOCIATED WITH HIGH POST-DISCHARGE MORTALITY

2006 expressed-sequence tags derived from human chromosome 7-enriched cDNA libraries

21 SELF IMAGE OF ADOLESCENTS WITH SHORT STATURE AS MEASURED BY HUMAN FIGURE DRAWINGS

The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR

A 32-year experience in 100 patients with giant paraesophageal hernia : The case for abdominal approach and selective antireflux repair. Discussion

6.57 Identifying Associations Between Phonology and Mental Health

[8] Structural studies of DNA three-way junctions

911 Spleen Preserving Laparoscopic Distal Pancreatectomy for a Solid Pseudopapillary Tumor in a Male Patient. (This Video Demonstrates Technical Details of a Rare Tumor of the Pancreas in a Male Patient. Only Few Cases Have Been Reported in Males)

Abdominal Complications after Severe Burns. Discussion

About the Author

About the Authors

About the Contributors

Abstract 1129: How to develop ACC1 inhibitors targeting lipid metabolism and oncogenic signaling pathways effectively and safely

Abstract 1321: Castration-resistant prostate cancer: BAY 1024767 blocks function of mutated androgen receptor

Abstract 1887: Preclinical evaluation of a novel interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor in combination with PI3K inhibitor copanlisib or BTK inhibitors in ABC-DLBCL

Abstract 1921: Universal genetic testing for hereditary cancer syndromes in an under-represented minority population

Abstract 2718: Synthesis and characterization of novel benzylpyrazole-based BUB1 kinase inhibitors with anti-tumor activity

Abstract 2828: Rapid identification of potent and highly selective, oral PTEFb Inhibitor BAY 1143572 with first in class potential

Abstract 287: BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity

Abstract 3022: BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFb/CDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia (AML)

Abstract 3022: BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFbCDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia (AML)

Abstract 3090: Novel Mps1 kinase inhibitors with potent anti-tumor activity

Abstract 4538: BAY 1112054, a highly selective, potent and orally available inhibitor of PTEFb/CDK9, shows convincing anti-tumor activity

Abstract 4851: Second generation 2,3-dihydroimidazo[1,2-c]quinazoline PI3K inhibitors: development of BAY 1082439, a novel balanced PI3Ká / PI3Kâ inhibitor

Suchergebnisse filtern